|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 帕博利珠单抗治疗伴脑转移NSCLC患者的一项非随机、开放Ⅱ期试验的长期随访结果和生物标志物分析显示文摘背景与目的我们开展了一项帕博利珠单抗用于伴未治疗脑转移的非小细胞肺癌(non-small cell lung cancer,NSCLC)或黑色素瘤患者的疗效和安全性的II期试验,旨在评估程序性死亡受体1(programmed cell death 1,PD-1)抑制剂在中枢神经系统(central nervous system,CNS)中的疗效。中期结果已发表,现报道对NSCLC队列的更新分析结果。方法这是一项开放性、单中心、II期试验。纳入标准:年龄≥18岁,诊断为晚期NSCLC并伴有≥1个5 mm-20 mm脑转移病灶,既往从未治疗或之前放疗后进展,无神经系统症状,不需要激素治疗且美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)<2分。患者每2周接受一次帕博利珠单抗(10 mg/kg)治疗。队列1为程序性死亡配体1(programmed cell death ligand 1,PD-L1)≥1%的患者,队列2为PD-L1<1%或未评估的患者。主要终点是脑转移患者缓解比例。所有经治患者均纳入疗效与安全性终点的分析。该研究已结束入组,并于Clinicaltrials.gov登记注册,注册号为NCT02085070。结果2014年3月31日-2018年5月21日,共42例患者接受治疗。中位随访时间为8.3个月(IQR:4.5个月-26.2个月)。队列1的37例患者中11例有脑转移缓解[29.7%(95%CI:15.9%-47.0%)]。队列2未观察到缓解。治疗相关的3级-4级不良事件(adverse events,AEs)包括2例肺炎、1例全身症状、1例结肠炎、1例肾上腺皮质功能不全、1例高血糖症和1例低钾血症。6例(14%)患者发生了治疗相关的严重不良事件,包括肺炎、急性肾损伤、低钾血症和肾上腺皮质功能不全。没有观察到治疗相关死亡病例。结论帕博利珠单抗治疗PD-L1≥1%的NSCLC伴脑转移患者有效,且对所有纳入的未经治疗的脑转移患者安全。需要进一步探索免疫治疗用于NSCLC合并CNS转移。 | Sarah B GOLDBERG Kurt A SCHALPER Scott N GETTINGER Amit MAHAJAN Roy S HERBST Anne C CHANG Rogerio LILENBAUM Frederick H WILSON Sacit Bulent OMAY James B YU Lucia JILAVEANU Thuy TRAN Kira PAVLIK Elin ROWEN Heather GERRSH Annette KOMLO Richa GUPTA Hailey WYATT Matthew RIBEIRO Yuval KLUGER Geyu ZHOU Wei WEI Veronica L CHANG Harriet M KLUGER 董晓荣(翻译/校对) | 2021 | 中国肺癌杂志2021，24，9： | 34 |
| 2 | Ribosome Inactivating Proteins from Plants Inhibiting Viruses显示文摘Many plants contain ribosome inactivating proteins (RIPs) with N-glycosidase activity, which depurinate large ribosomal RNA and arrest protein synthesis. RIPs so far tested inhibit replication of mRNA as well as DNA viruses and these proteins, isolated from plants, are found to be effective against a broad range of viruses such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and herpes simplex virus (HSV). Most of the research work related to RIPs has been focused on antiviral activity against HIV; however, the exact mechanism of antiviral activity is still not clear. The mechanism of antiviral activity was thought to follow inactivation of the host cell ribosome, leading to inhibition of viral protein translation and host cell death. Enzymatic activity of RIPs is not limited to depurination of the large rRNA, in addition they can depurinate viral DNA as well as RNA. Recently, Phase I/II clinical trials have demonstrated the potential use of RIPs for treating patients with HIV disease. The aim of this review is to focus on various RIPs from plants associated with anti-HIV activity. | Inderdeep Kaur R C Gupta Munish Puri | 2011 | Virologica Sinica2011，26，6： | 7 |
| 3 | Concurrent removal of intravitreal lens fragments after phacoemulsification with pars plana vitrectomy prevents development of retinal detachment显示文摘AIM: To evaluate the outcomes of 'concurrent vitrectomy' to retrieve dislocated lens fragment during phacoemulsification.METHODS: In a retrospective, observational case series, data of patients who underwent 'concurrent' pars plana vitrectomy(PPV) for dislocated lens fragments between the period 2000 and 2008 were reviewed. Data collected included patient demographics, pre-operative visual acuity, intra-operative occurrence of retinal breaks, duration of follow up, post-operative intraocular pressure, final best-corrected visual acuity(BCVA),presence of cystoid macular edema(CME) and occurrence of rhegmatogenous retinal detachment(RRD).· RESULTS: A total of 58 eyes of 58 patients were included in the study. At 12 mo the mean postoperative BCVA was log MAR 0.17(20/30) with a range of log MAR0 to 0.69(20/20 to 20/100), with 96.6%(56/58) of patients showing post- operative improvement in visual acuity(P =0.005). None of the patients developed postoperative retinal detachment, endophthalmitis or non-resolving uveitis at 12 mo.CONCLUSION: Our study results suggest concurrent PPV for retained lens fragments after cataract surgery is beneficial and may decrease the risk of glaucoma and prevent development of RRD. | Kakarla V Chalam Ravi K Murthy Joshua C Priluck Vijay Khetpal Shailesh K Gupta | 2015 | International Journal of Ophthalmology(English edition)2015，8，1： | 4 |
| 4 | A Sharper Condition for the Solvability of a Three-point Second-order Boundary Value Problem 显示文摘 | Gupta C P | 1997 | J Math Anal Appl1997，205，2： | 3 |
| 5 | 聚辛烯与硫磺交联剂对橡胶沥青性能改善作用研究显示文摘为评价聚辛烯与硫磺双掺对橡胶沥青性能的改善作用,制备不同掺量双掺改性橡胶沥青,采用黏度和DSR等试验测试其使用性能。结果表明:黏度对双掺改性橡胶沥青高温性能区分度较针入度和软化点好;双掺能使橡胶沥青高温性能明显改善,且降低其应力敏感性,但也增强了温度敏感性;聚辛烯与0.1%硫磺双掺能改善橡胶沥青低温性能,同时双掺能增强橡胶沥青弹性恢复和储存稳定性,其中弹性恢复随两者掺量的增加逐渐提高,储存稳定性则在1.0%聚辛烯掺量下效果较好;考虑综合性能,推荐的聚辛烯与硫磺掺量分别为1.0%和0.1%。 | 李平 翟龙 刘豪斌 刘连国 彭卓祥(译) Padhan R K Gupta A A Mohanta C S | 2018 | 中外公路2018，38，5： | 3 |
| 6 | Abrasive Wear Characteristics of Carbon and Low Alloy Steels for Better Performance of Farm Implements显示文摘The low stress abrasion behaviours of heat treated mild, medium carbon and high C - low Cr steels, which are generally used in making farm implements, have been investigated. The simple heat treatment greatly improves the hardness, tensile strength and abrasion resistance of medium carbon and high C - low Cr steels. The results indicate that the material removal during abrasion is controlled by a number of factors, such as hardness, chemical composition, microstructure and heat treatment conditions. The conclusion is that the heat treated high C - low Cr steel and mild steel carburized by using coaltar pitch provide the best hardness and abrasion resistance and thus appear to be the most suitable materials for making agricultural tools. | M.Kumar and R. C Gupta(Centre of Advanced Study, Dept. of Metallurgical Engineering, Institute of Technology,Banaras Hindu University, Vaanasi -221 005, India) | 1995 | Journal of Materials Science & Technology1995，11，2： | 2 |
| 7 | Erythropoietin therapy after out-of-hospital cardiac arrest:A systematic review and meta-analysis显示文摘AIM To assess safety and efficacy of early erythropoietin(Epo) administration in patients with out-of-hospital cardiac arrest(OHCA).METHODS A systematic literature search was performed using PubM ed,MEDLINE,EMBASE,EBSCO,CINAHL,Web of Science and Cochrane databases,of all studies published from the inception through October 10,2016.Inclusion criteria included:(1) Adult humans with OHCA and successful sustained return of spontaneous circulation;and(2) studies including mortality/brain death,acute thrombotic events as their end points.Primary efficacyoutcome was 'brain death or Cerebral Performance Category(CPC) score of 5'.Secondary outcomes were 'CPC score 1,and 2-4','overall thrombotic events' and 'acute coronary stent thrombosis'.RESULTS We analyzed a total of 606 participants(n = 276 received Epo and n = 330 with standard of care alone) who experienced OHCA enrolled in 3 clinical trials.No significant difference was observed between the Epo and no Epo group in brain death or CPC score 5(OR = 0.77;95%CI:0.42-1.39),CPC score 1(OR = 1.16,95%CI:0.82-1.64),and CPC score 2-4(OR = 0.77,95%CI:0.44-1.36).Epo group was associated with increased thrombotic complications(OR = 2.41,95%CI:1.26-4.62) and acute coronary stent thrombosis(OR = 8.16,95%CI:1.39-47.99).No publication bias was observed.CONCLUSION Our study demonstrates no improvement in neurological outcomes and increased incidence of thrombotic events and acute coronary stent thrombosis in OHCA patients who were treated with Epo in addition to standard therapy. | Rahul Chaudhary Jalaj Garg Parasuram Krishnamoorthy Kevin Bliden Neeraj Shah Nayan Agarwal Rahul Gupta Abhishek Sharma Karl B Kern Nainesh C Patel Paul Gurbel | 2017 | World Journal of Cardiology2017，9，12： | 2 |
| 8 | Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model显示文摘AIM To investigate the therapeutic potential of two recombinant proteins, Survivin and luteinizing hormone-releasing hormone (LHRH) fusion protein [LHRH(6 leu)-LTB] for immunotherapy of breast cancer.METHODS Murine 4 T-1 breast cancer model was used to evaluate the efficacy of recombinant proteins in vivo. Twenty four Balb/c mice were divided into 4 groups of 6 mice each. Recombinant Survivin and LHRH fusion protein, alone or in combination, were administered along with immunomodulator Mycobacterium indicus pranii (MIP) in Balb/c mice. Unimmunized or control group mice were administered with phosphate buffer saline. Each group was then challenged with syngeneic 4 T-1 cells to induce the growth of breast tumor. Tumor growth was monitored to evaluate the efficacy of immune-response in preventing the growth of cancer cells.RESULTS Preventive immunization with 20 μg recombinant Survivin and MIP was effective in suppressing growth of 4 T-1 mouse model of breast cancer (P = 0.04) but 50 μg dose was ineffective in suppressing tumor growth. However, combination of Survivin and LHRH fusion protein was more effective in suppressing tumor growth (P = 0.02) as well as metastasis in vivo in comparison to LHRH fusion protein as vaccine antigen alone.CONCLUSION Recombinant Survivin and MIP suppress tumor growth significantly. Combining LHRH fusion protein with Survivin and MIP enhances tumor suppressive effects marginally which provides evidence for recombinant Survivin and LHRH fusion protein as candidates for translating the combination cancer immunotherapy approaches. | Himani Garg Rohit Singh Hada Jagdish C Gupta G P Talwar Shweta Dubey | 2018 | World Journal of Clinical Oncology2018，9，8： | 2 |
| 9 | Relations for reliability measures under length biased sampling显示文摘 | GUPTA R C KEATING J P | 1986 | Scandinavian Journal of Statistics1986，13，： | 1 |
| 10 | On the GI/M/1/N queue with working vacations-analytic analysis and computation显示文摘 | Banik A D Gupta U C Pathak S S | 2007 | Applied Mathematics Modeling2007，，： | 1 |
| 11 | Short-term outcomes of 23-gauge pars plana vitrectomy显示文摘 | Gupta OP Ho A Kaiser PK Regillo C Chen S Dyer D | 2008 | Am J Ophthalmol2008，146，2： | 1 |
| 12 | A Sharper Condition for the Solvability of a Three-point Second Order Boundary Value Problem显示文摘 | Gupta C P | 1997 | J Math Anal Appl1997，205，： | 1 |
| 13 | Boron toxicity and deficiency: A Review 显示文摘 | U C Gupta Y W Jame C A Campbell | 1985 | Canadian Journal of Soil Science1985，65，3： | 1 |
| 14 | Biochemistry and physiology of bioluminescent bacteria显示文摘 | HASTINGS J W POTRIKUS C J GUPTA S C | 1985 | Advances Microbial Physiology1985，26，： | 1 |
| 15 | T ( p-e)/QT ratio as an index of arrhythmogenesis 显示文摘 | Gupta P Pate1 C Patel H | 2008 | J Electrocardiol2008，41，6： | 1 |
| 16 | Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer ceils : control of transcription by DNA methylation and intronic sequences 显示文摘 | Lu A Gupta A Li C | 2001 | Oncogene2001，20，17： | 1 |
| 17 | Solvability of a three-point nonlinear boundary value problem for a second order ordinary differential equations显示文摘 | GUPTA C P | 1992 | J Math Anal Appl1992，168，： | 1 |
| 18 | On the moments of residual life in reliability and some characterization results 显示文摘 | GUPTA P L GUPTA R C | 1983 | Communications in Statistics1983，12，4： | 1 |
| 19 | Molecular markers and their applications in wheat breeding显示文摘 | P K Gupta R K Varshney P C Sharma B Ramesh | 1999 | Plant Breeding1999，118，： | 1 |
| 20 | Serum lipids and uric acid relationship in ischemic thrombotic cerebrovascular disease显示文摘 | Bansal B C Gupta R R Bansal M R | 1975 | Stroke1975，6，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员